ArticleNeuro-oncology2022

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant.

Emmanuel de Billy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.